IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
High serum levels of IL-6 correlate with poor outcome in breast cancer patients. However, no data are available on the relationship between IL-6 and mammary stem/progenitor cells, which may fuel the genesis of breast cancer in vivo. Herein, we address this issue in the MCF-7 breast cancer cell line and in primary human mammospheres (MS), multicellular structures enriched in stem/progenitor cells of the mammary gland. MS from node invasive breast carcinoma tissues expressed IL-6 mRNA at higher levels than did MS from matched non-neoplastic mammary glands. In addition, IL-6 mRNA was detected only in basal-like breast carcinoma tissues, an aggressive breast carcinoma variant showing stem cell features. IL-6 treatment triggered Notch-3-dependent upregulation of the Notch ligand Jagged-1 and promotion of MS and MCF-7-derived spheroid growth. Moreover, IL-6 induced Notch-3-dependent upregulation of the carbonic anhydrase IX gene and promoted a hypoxia-resistant/invasive phenotype in MCF-7 cells and MS. Finally, autocrine IL-6 signaling relied upon Notch-3 activity to sustain the aggressive features of MCF-7-derived hypoxia-selected cells. In conclusion, these data support the hypothesis that IL-6 induces malignant features in Notch-3-expressing stem/progenitor cells from human ductal breast carcinoma and normal mammary gland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-6 is an MSC-secreted inflammatory cytokine displaying pro-survival, pro-growth and pro-angiogenic activities [11], which has been implicated in tumor progression of various cancers including breast cancer [113, 114].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Research works printed but not linked: 4
- Zhang, 1999, Anticancer Res., 19, 1427
- Sehgal, 1991, EXS., 59, 178
- Conze, 2001, Cancer Res., 61, 8851
- Trikha, 2003, Clin. Cancer Res., 9, 4653
Cited by
Items 601–700 of 839
Pyroptosis-Related Signatures for Predicting Prognosis in Breast Cancer
Ren, T., Guo, X., Zhang, J., & Liu, Z. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.788437 · Cited by 9
Yang, J.-R., Wang, J., Li, H., Gao, S., Fan, Y., & Wang, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.746643 · Cited by 9
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?
Ruiu, R., Lorenzo, A. D., Cavallo, F., & Conti, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.877384 · Cited by 9
The Role of the “Cancer Stem Cell Niche” in Cancer Initiation and Progression
Noll, J. E., Vandyke, K., & Zannettino, A. C. W. (2014) · InTech eBooks · doi:10.5772/58598 · Cited by 9
Sun, B., & Shen, H. Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.013 · Cited by 9
Itou, J., Tanaka, S., Sato, F., Akiyama, R., Kawakami, Y., & Toi, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.10.004 · Cited by 9
Dichotomy of Notch signalling in regulating tumour immune surveillance
Khosla, R., Vyas, A. K., & Trehanpati, N. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12744 · Cited by 9
Enrichment of tumor-initiating breast cancer cells within a mammosphere-culture microdevice
Saadin, K., Burke, J. M., Patel, N. P., Zubajlo, R. E., & White, I. M. (2013) · Biomedical Microdevices · doi:10.1007/s10544-013-9755-y · Cited by 9
Vitali, E., Valente, G., Panzardi, A., Laffi, A., Zerbi, A., Uccella, S., Mazziotti, G., & Lania, A. G. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02221-1 · Cited by 8
Masoumi, H., Soltani, A., & Ghatrehsamani, M. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05114-w · Cited by 8
Pastoreková, S., Baráthová, M., Kopáček, J., & Pastorek, J. (2009) · Wiley eBooks · doi:10.1002/9780470508169.ch8 · Cited by 8
Protumor effects of proinflammatory mediators in breast cancer
Sirotković-Skerlev, M., Kulić, A., Bradić, L., & Čaćev, T. (2012) · Periodicum Biologorum · Cited by 8
Vedoya, G. M., Nigro, M. M. L., & Martín, G. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.105018 · Cited by 7
Mendelian Randomization Study on Causal Association of IL-6With Breast Cancer
Zhang, M., Ma, N., & Wang, R. (2023) · Clinical Breast Cancer · doi:10.1016/j.clbc.2023.01.015 · Cited by 7
Liu, L., Wu, Y., Kuo, S., Ho, C., Way, T., & Chen, S.-T. (2018) · Anticancer Research · doi:10.21873/anticanres.12530 · Cited by 7
Mendoza, M. S., Camacho-Camacho, C., Rojas‐Oviedo, I., Prado-García, H., Barrera, D., Martínez-Reza, I., Larrea, F., & García-Becerra, R. (2020) · PubMed · Cited by 7
Procalcitonin beyond the acute phase: novel biomediator properties?
Panico, C., & Nylén, E. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-189 · Cited by 7
Salah, M., Nishimoto, Y., Kohno, S., Kondoh, A., Kitajima, S., Muranaka, H., Nishiuchi, T., Ibrahim, A., Yoshida, A., & Takahashi, C. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22444 · Cited by 7
Universal and Specific Functions of STAT3 in Solid Tumours
Avalle, L., Regis, G., & Poli, V. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0891-8_17 · Cited by 7
Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts
Morancho, B., Fluck, M. F. Z., Esgueva, A., Morales, C. B., Cosimo, S. D., Prat, A., Cortés, J., Arribas, J., & Rubio, I. T. (2016) · Oncotarget · doi:10.18632/oncotarget.11815 · Cited by 7
Trinschek, B., Lüssi, F., Haas, J., Wildemann, B., Zipp, F., Wiendl, H., Becker, C., & Jonuleit, H. (2013) · PLoS ONE · doi:10.1371/annotation/0e76c09e-75b2-493a-90fd-cda3187a0888 · Cited by 7
Epithelial Stem Cells: Making, Shaping and Breaking the Niche
Ferraces-Riegas, P., Galbraith, A. C., & Doupé, D. P. (2022) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_686 · Cited by 6
Upregulation of TLR5 indicates a favorable prognosis in prostate cancer
Liang, H., Zhang, L., Liu, Z., Hoden, B., DeRubeis, D., Zhang, Y., Wang, F., & Zhang, D. (2023) · The Prostate · doi:10.1002/pros.24545 · Cited by 6
Protein Kinase CK2 and Dysregulated Oncogenic Inflammatory Signaling Pathways
Benveniste, E. N., Gray, G. K., & McFarland, B. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-14544-0_15 · Cited by 6
Carbonic Anhydrase IX: From Biology to Therapy
Pastoreková, S., & Supuran, C. T. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9167-5_6 · Cited by 6
Huffel, S. C. V., Tham, J. M., Zhang, X., Lim, K.-P., Yang, C., Tan, Y., Ong, F., Lee, I. Y., & Hong, W. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-13 · Cited by 6
De l’eau au moulin de thérapies ciblant l’interleukine-6 dans les tumeurs épithéliales
Gougèlet, A., Mansuy, A., & Blay, J. (2008) · médecine/sciences · doi:10.1051/medsci/20082489694 · Cited by 6
Effects of bromodomain and extra-terminal inhibitor JQ1 and interleukin-6 on breast cancer cells
Sharifhoseini, A., Heshmati, M., Soltani, A., Entezam, M., Shirzad, H., Sedehi, M., Judd, B. A., Jami, M., & Ghatrehsamani, M. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08718-5 · Cited by 5
Interleukin-6 as a Biomarker for Breast Cancer Prognosis and Therapeutic Response
Sulaiman, S. H., & Rwandzy, H. I. I. (2024) · Qalaai Zanist Scientific Journal · doi:10.25212/lfu.qzj.9.3.49 · Cited by 5
The crosstalk of breast cancer and ischemic heart disease
Luo, Y., Liu, J., Qu, P., Han, S., Li, X., Wang, Y., Su, X., Zeng, J., Li, J., Deng, S., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02428-6 · Cited by 5
Cell lineage determinants as regulators of breast cancer metastasis
Lu, W., & Kang, Y. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9644-y · Cited by 5
Gennari, A., Sormani, M. P., Puntoni, M., Martini, V., Amaro, A. A., Bruzzi, P., & Pfeffer, U. (2020) · Breast Care · doi:10.1159/000509207 · Cited by 5
THE LEVEL OF CYTOKINES IN THE SALIVA OF PATIENTS WITH BREAST CANCER
Bel’skaya, L. V., & Константинович, К. В. (2019) · Voprosy Onkologii · doi:10.37469/0507-3758-2019-65-6-825-831 · Cited by 5
Liu, J., Shi, Y., Wu, M., Xu, M., Zhang, F., He, Z., & Tang, M. (2022) · PubMed · doi:10.12122/j.issn.1673-4254.2022.07.21 · Cited by 5
Inhibition of AIM2 expression enhance treatment effect of osimertinib in treatment of glioma
Wang, H., Zhang, H., & Wei, Q. (2024) · Folia Neuropathologica · doi:10.5114/fn.2024.140806 · Cited by 5
Potential Signaling Pathways Activated in Cancer Stem Cells in Breast Cancer
Gotoh, N. (2011) · InTech eBooks · doi:10.5772/14076 · Cited by 5
Stem cell and cancer stem cell games on the ECM field
Kamble, S. C., & Bapat, S. A. (2013) · Journal of Cancer Stem Cell Research · doi:10.14343/jcscr.2013.1e1002 · Cited by 5
Obesity and cancer stem cells: Roles in cancer initiation, progression and therapy resistance
Xie, W., & Li, J. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i4.120 · Cited by 5
Todorović‐Raković, N., Radulović, M., Vujasinović, T., Milovanović, J., & Nikolić‐Vukosavljević, D. (2017) · Cytokine · doi:10.1016/j.cyto.2017.11.020 · Cited by 5
Tiganis, T. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3649-6_5 · Cited by 5
Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma
Chen, S. (2012) · InTech eBooks · doi:10.5772/1484 · Cited by 5
Kumar, J., Fraser, F. W., Riley, C., Ahmed, N., McCulloch, D. R., & Ward, A. C. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.389 · Cited by 5
Samanta, D., Gilkes, D. M., Xiang, L., Chaturvedi, P., & Semenza, G. L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.497729 · Cited by 5
Miracle, C. E., McCallister, C. L., Denning, K. L., Russell, R., Allen, J., Lawrence, L. M., Legenza, M. T., Krutzler-Berry, D., & Salisbury, T. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910592 · Cited by 4
Sarf, E. A., Dyachenko, E. I., & Bel’skaya, L. V. (2024) · Biomedicines · doi:10.3390/biomedicines12061329 · Cited by 4
Adipokines: Soluble Factors from Adipose Tissue Implicated in Cancer
Paz-Filho, G., Mishra, A. K., & Licinio, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7660-3_5 · Cited by 5
Tobin, G., Kalupahana, R. S., & Kulk, M. (2013) · InTech eBooks · doi:10.5772/55794 · Cited by 4
Son, H., Park, I., Kim, J. Y., Kim, D. K., Illeperuma, R. P., Bae, J. Y., Lee, D. Y., Oh, E., Jung, D., Williams, D. R., et al. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25200 · Cited by 4
Stem Cells of the Breast and Cancer Therapy
Groner, B., Vafaizadeh, V., Brill, B., & Klemmt, P. A. B. (2010) · Women s Health · doi:10.2217/whe.10.5 · Cited by 4
Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model
Andrade, F. D. O., Yu, W., Zhang, X., Carney, E., Hu, R., Clarke, R. C., Fitzgerald, K. T., & Hilakivi-Clarke, L. A. (2019) · Endocrine Related Cancer · doi:10.1530/erc-18-0393 · Cited by 4
Cancer Stem Cells: An Ever-Hiding Foe
Wilczyński, J. R. (2022) · Experientia supplementum · doi:10.1007/978-3-030-91311-3_8 · Cited by 4
Cellular and Molecular Mechanisms of Tumor Promotion
Sadler, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64273-3 · Cited by 4
CRISPR/Cas-based detection strategies for tumor biomarker detection
Yang, K., Wang, T., Zhu, Q., & Shen, C. (2025) · Analytical Methods · doi:10.1039/d5ay01150g · Cited by 3
Lazarte, J. M. S., Aare, M., Padakanti, S. C., Bagde, A., Nathani, A., Meeks, Z., Sun, L. J., Li, Y., & Singh, M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101318 · Cited by 3
Wang, Y., Zhang, X., Liu, C., Shi, J., Liu, T., Chen, Y., Zheng, X. M., Bu, Z., & Shi, H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1669838 · Cited by 3
Haj‐Mirzaian, A., Afshari, K., & Abdolghaffari, A. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_24 · Cited by 3
The Pituitary Tumors and Their Tumor-Specific Microenvironment
Kameda-Smith, M. M., & Lu, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59038-3_7 · Cited by 3
Bioinspired Materials for Sensor and Clinical Applications: Two Case Studies
Alfinito, E., Ciccarese, M., Maruccio, G., Monteduro, A. G., & Rizzato, S. (2023) · Chemosensors · doi:10.3390/chemosensors11030195 · Cited by 3
Subtype-specific role for Jagged1 in promoting or inhibiting breast tumor formation
Chung, W.-C., Wang, W., Challagundla, L., Moore, C. D., Egan, S. E., & Xu, K. (2025) · Oncogenesis · doi:10.1038/s41389-025-00545-6 · Cited by 3
The Mechanisms of Breast Cancer Metastasis
Russo, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-40815-6_7 · Cited by 3
A Glance into Cancer Stem Cells
Khodayari, H., Chamani, R., Khodayari, S., & Alizadeh, A. M. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Pandith, A. A., Bhat, I. A., Mansoor, S., Koul, A. M., Manzoor, U., Anwar, I., Mohammad, F., Aein, Q. U., Baba, S. M., & Vlădulescu, C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.99363 · Cited by 3
Miao, X., Jiang, P., Zhang, X., Li, X., Wu, Z., Jiang, Y., Liu, H., Xie, W., Li, X., Shi, B., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01839-23 · Cited by 3
Liang, B., Zhao, H., Che, J., Wang, H., & Shi, G. (2014) · Medical Oncology · doi:10.1007/s12032-014-0089-2 · Cited by 3
Interleukin-6 affects cancer cell biology
Nishino, H. (2016) · 耳鼻咽喉科免疫アレルギー · doi:10.5648/jjiao.34.13 · Cited by 3
Chatterjee, P., & Banerjee, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115866 · Cited by 4
Cullinane, C. M., Connolly, R. M., Corrigan, M. A., Redmond, H. P., & Foley, C. (2024) · European Journal of Immunology · doi:10.1002/eji.202451049 · Cited by 3
Breast Cancer Stem Cells: Responsible for Therapeutic Resistance and Relapse?
Körkaya, H., & Malik, F. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5647-6_21 · Cited by 3
Lin, S., & Fu, S. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2012.12.016 · Cited by 3
Activation of Janus Kinases During Tumorigenesis
Schmidt, J. W., & Wagner, K. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0891-8_15 · Cited by 3
Cytokine Networks and Cancer Stem Cells
Liongue, C., Ward, A. C., Duan, W., & Shigdar, S. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-21030-8_3 · Cited by 3
Sullivan, N. J. (2009) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 3
Chou, A. S., Chen, H.-C., Li, C.-R., Hsieh, C.-H., Ting, L., & Liao, S.-K. (2011) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2011.0958 · Cited by 3
Breast cancer stem cells: a moving target for cancer nanomedicine
Mollenhauer, J., Knoop, A. S., Bak, M., Lænkholm, A., Thomassen, M., Kruse, T. A., & Høilund‐Carlsen, P. F. (2012) · European Journal of Nanomedicine · doi:10.1515/ejnm-2012-0006 · Cited by 3
Chou, A. S., Wang, H., Chen, H.-C., Tsai, M.-H., Chuang, C., & Liao, S.-K. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-169 · Cited by 3
Meng, X. (2019) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 3
The Two-Way Role of Jagged1 in Cancer: A Focus on CRC
Zema, S., Fazio, F. D., Palermo, R., Talora, C., & Bellavia, D. (2025) · Cells · doi:10.3390/cells14221815 · Cited by 2
Cellules souches du cancer du sein : prendre le cancer à la racine
Launay, S., Ginestier, C., Birnbaum, D., & Charafe‐Jauffret, E. (2012) · ONCOLOGIE · doi:10.1007/s10269-012-2198-x · Cited by 2
Cancer stem cells are new vistas for predicting the course of breast cancer
Maslyukova, E. A., Zabroda, S. I., Li, K., Pozharissky, K. M., Раскин, Г. А., & Корытов, О. В. (2015) · Tumors of female reproductive system · doi:10.17650/1994-4098-2015-11-3-10-14 · Cited by 2
Kolon Kanserinde IL-6 Sitokinin Karbonik anhidraz III Gen İfadesi Üzerindeki Etkisinin İncelenmesi
BABACAN, D., Türkoğlu, S. A., & KOCKAR, F. T. (2023) · Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi · doi:10.21597/jist.1183875 · Cited by 2
Al-Maliki, N. S., & Zedan, Z. K. (2023) · International Journal of Pharmaceutical and Bio-Medical Science · doi:10.47191/ijpbms/v3-i11-03 · Cited by 2
Kim, S., HONG, W.-K., Choi, H. S., & Lee, D. (2024) · In Vivo · doi:10.21873/invivo.13817 · Cited by 2
Epithelial-Mesenchymal Transition and Cancer Stem Cells
Ouyang, G. (2011) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/19282 · Cited by 3
Self-Renewal Pathways in Mammary Stem Cells and Carcinogenesis
Deng, L., Xu, J., Wang, D., & Liu, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-21030-8_6 · Cited by 2
Cancer Stem Cells and the Microenvironment
Körkaya, H., Davis, A., & Wicha, M. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00010-x · Cited by 2
Quantitative Analysis of Bortezomib-Induced IL-8 Gene Expression in Ovarian Cancer Cells
Singha, B., Phyo, S. A., Gatla, H. R., & Vancurova, I. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0928-5_27 · Cited by 2
Regulation of Breast Cancer Stem Cells by Mesenchymal Stem Cells in the Metastatic Niche
Malik, F. A., Körkaya, H., Clouthier, S. G., & Wicha, M. S. (2015) · Wiley eBooks · doi:10.1002/9781118670613.ch7 · Cited by 2
Physiological and Pharmacological Regulation of the STAT3 Pathway in Cancer
Xiang, M. H. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 2
Histone demethylase JMJD6 enhances cancer stem cell phenotype in oral squamous cell carcinoma cells
Lee, C. R. (2014) · eScholarship (California Digital Library) · Cited by 2
Dinca, S. C., Greiner, D., Weidenfeld, K., Bond, L., Barkan, D., & Jorcyk, C. L. (2020) · Research Square · doi:10.21203/rs.3.rs-57684/v1 · Cited by 2
Targeting MDSC-HTR2B to Improve Immune Checkpoint Inhibitors in Breast to Brain MetastasisPreprint
Iyer, M., Das, D., Baugh, A. G., Shah, P., Nakamura, B. N., Sedighi, S., Reed, M., Jang, J. K., Chow, F. E., Torres, E. T. R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.20.599939 · Cited by 2
The Interplay Between Inflammation and Cancer Progression: Implications for Therapy
Basharat, B., Jahan, N., Mishra, A., Alam, J., Khan, Y. T., Hassan, I. M., Jilani, N. Z., & Badar, M. S. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_474 · Cited by 1
Ahmad, W., Panicker, N. G., Rizvi, T. A., & Mustafa, F. (2026) · Computational and Structural Biotechnology Journal · doi:10.34133/csbj.0055 · Cited by 1
Cell plasticity in cancer and therapy resistance
Seo, Y., Jang, J., & Park, J. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01869-y · Cited by 1
Larsen, J. E., & Minna, J. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.044 · Cited by 1
Cellular and Molecular Signatures of Androgen Ablation of Prostate Cancer
Tepper, C. G., & Kung, H.-J. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_22 · Cited by 1
STAT3 polymorphisms in North Africa and its implication in breast cancer
Ziadi, W., Boussetta, S., Elkamel, S., PAKSTIS, A. J., Kídd, K. K., Medimegh, I., Elgaaïed, A. B. A., & Cherni, L. (2021) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1744 · Cited by 1
Potential Therapeutic Molecular Targets for Nasopharyngeal Carcinoma
Chen, S. (2012) · InTech eBooks · doi:10.5772/33274 · Cited by 1
Targeting Breast Cancer Stem Cells
Pham, P. V. (2015) · SpringerBriefs in stem cells · doi:10.1007/978-3-319-22020-8_6 · Cited by 1
Liu, Q., Yu, F.-Y., Tang, W., Su, S.-C., & Song, E.-W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397833-2.00008-x · Cited by 1
Metadata
- Authors
- Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., Chieco, P., & Bonafè, M.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- University of Bologna (IT)
- Corresponding author
- Bonafè, Massimiliano
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-12-03
- Volume
- 117
- Issue
- 12
- Pages
- 3988-4002
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2096439
- OpenAlex
- W2114817620
- Cited by
- 779
- References
- 61
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 21 · 2023: 29 · 2022: 27 · 2021: 27 · 2020: 55 · 2019: 40 · 2018: 55 · 2017: 52 · 2016: 45 · 2015: 64 · 2014: 71 · 2013: 70 · 2012: 53
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Fondazione Cassa di Risparmio in Bologna
- Università di Bologna
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- interleukin-6, mammospheres, mammary stem/progenitor cells, breast ductal carcinoma, Notch3, Jagged1, carbonic anhydrase IX, hypoxia tolerance, breast cancer invasion, basal-like breast cancer, MCF-7 cells, autocrine signaling, tumor microenvironment
- MeSH terms
- Carbonic Anhydrase IX, Receptor, Notch3, Serrate-Jagged Proteins, Jagged-1 Protein, Antigens, Neoplasm, Breast Neoplasms, Calcium-Binding Proteins, Carbonic Anhydrases, Female, Humans, Membrane Proteins, Neoplasm Invasiveness, Neoplasm Proteins, RNA, Messenger, RNA, Neoplasm, Stem Cells, Cell Hypoxia, Interleukin-6, Up-Regulation, Gene Expression Regulation, Neoplastic, Spheroids, Cellular, Autocrine Communication, Intercellular Signaling Peptides and Proteins, Mammary Glands, Human, Carcinoma, Ductal, Cell Line, Tumor, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.